-
, cancer cachexia and body composition, radiomics and tumour microenvironment. Future plans include tumour metabolic imaging and mass spectrometry metabolomics. TRACERx is supported by the excellent
-
heterogeneity. TRACERx has enabled additional analyses in the areas of immunology, circulating biomarkers, cancer cachexia and body composition, radiomics and tumour microenvironment. Future plans include tumour
-
expressed by epithelial cells that regulate the composition and activity of gamma delta T cells that naturally populate body surfaces in model animals and in humans. His team is responsible for the 'Lymphoid
Searches related to composite
Enter an email to receive alerts for composite positions